IRIS Diabetic Retinopathy Diagnostic Solution

Our FDA Type II clearance provides an end-to-end diagnostic solution for early detection of disease, from patient identification to reimbursement and referral. Practices can increase access, improve care coordination, reduce costs, and achieve HEDIS compliance. IRIS equips primary care providers and practices in the health care industry with the capability to take retinal images for their diabetic population. These fundus photography images taken of the retina are diagnosed by Ophthalmologist through our telemedicine platform. The final report with a diagnosis is sent back to the PCP through a fully bidirectional EMR integration. The IRIS solution in primary care helps organizations end preventable blindness due to diabetic retinopathy and macular edema.